Skip to main content
Equibles

GOLDMAN SACHS GROUP INC

Position in ZNTL — Zentalis Pharmaceuticals, Inc.

CIK 886982 NEW YORK, NY
Back to ZNTL Full portfolio

Position in ZNTL

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$1,806,934
+$724,268 QoQ
Shares Held
372,564
-19.5% QoQ
Ownership
0.520%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#30
of 114 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ZNTL Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GOLDMAN SACHS GROUP INC holds $13,181,249,908 across 360 Biotechnology names. ZNTL ranks #230 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 2,481,761 $1,232,765,138
2 REGN
Regeneron Pharmaceuticals, Inc.
 1,163,191 $725,296,113
3 ROIV
Roivant Sciences Ltd.
 18,556,458 $656,713,046
4 TECH
BIO-TECHNE Corp
 7,343,324 $518,805,838
5 RVMD
Revolution Medicines, Inc.
 2,133,101 $399,487,154
6 MRNA
Moderna, Inc.
 4,671,950 $327,176,656
7 TNGX
Tango Therapeutics, Inc.
 9,980,620 $311,994,180
8 INCY
Incyte Corp
 2,305,782 $261,383,446

All Filings in ZNTL

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,806,934 372,564
2026-03-31 $1,082,666 462,678
2025-12-31 $159,586 118,212
2025-09-30 $521,183 345,155
2025-06-30 $999,648 861,767
2025-03-31 $725,664 456,393
2024-12-31 $2,781,863 918,107
2024-09-30 $2,333,353 634,064
2024-06-30 $2,532,743 619,253
2024-03-31 $5,232,319 332,000
2023-12-31 $4,437,147 292,881
2023-09-30 $4,478,615 223,261
2023-06-30 $20,694,206 733,577
2023-03-31 $3,507,870 203,946
2022-12-31 $7,862,292 390,382
2022-09-30 $7,328,270 338,332
2022-06-30 $11,171,716 397,570
2022-03-31 $12,238,449 265,246
2021-12-31 $11,883,477 141,369
2021-09-30 $15,349,923 230,341
2021-06-30 $4,484,174 84,289
2021-03-31 $2,247,992 51,809
2020-12-31 $11,633,676 223,983
2020-09-30 $1,051,669 32,171
2020-06-30 $663,636 13,820